Clariane SE (LTS:0OPS) Shares Outstanding (EOP): 357 Mil (As of Dec. 2025)


LTS:0OPS Clariane SE LTS:0OPS
61 GF Score
Price €4.10
GF Value €2.49
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clariane SE Shares Outstanding (EOP)?

Clariane SE LTS:0OPS -3.09% 61 Shares Outstanding (EOP) is 357 Mil as of Dec. 2025. GuruFocus rates LTS:0OPS with a GF Score™ of 61/100 and a GF Value™ of €2.49 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Clariane SE's shares outstanding for the quarter that ended in Dec. 2025 was 357 Mil.

Clariane SE's quarterly shares outstanding increased from Jun. 2025 (356 Mil) to Dec. 2025 (357 Mil). It means Clariane SE issued new shares from Jun. 2025 to Dec. 2025 .

Clariane SE's annual shares outstanding increased from Dec. 2024 (356 Mil) to Dec. 2025 (357 Mil). It means Clariane SE issued new shares from Dec. 2024 to Dec. 2025 .


Clariane SE  (LTS:0OPS) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Clariane SE Shares Outstanding (EOP) Related Terms


Clariane SE Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Clariane SE's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clariane SE Shares Outstanding (EOP) Chart

Clariane SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 168.42 169.62 170.82 355.72 356.50

Clariane SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 170.82 227.89 355.72 356.49 356.50

LTS:0OPS vs HCA, THC, DVA: Shares Outstanding (EOP) Comparison

For the Medical Care Facilities subindustry, Clariane SE's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clariane SE Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Clariane SE's Shares Outstanding (EOP) falls into.


LTS:0OPS
61GF Score
Clariane SE LTS:0OPS
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clariane SE Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 357 Mil mean?
Clariane SE (LTS:0OPS) has a Shares Outstanding (EOP) of 357 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Clariane SE and its competitors.
Is Clariane SE's Shares Outstanding (EOP) too high?
Clariane SE's current Shares Outstanding (EOP) is 357 Mil. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Shares Outstanding (EOP) compare to HCA and THC?
Clariane SE's Shares Outstanding (EOP) of 357 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Clariane SE and its competitors. Clariane SE's current Shares Outstanding (EOP) is 357 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (LTS:0OPS) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.49, compared to a current price of €4.10 — trading 64.8% above its estimated fair value. The current Shares Outstanding (EOP) is 357 Mil. Clariane SE's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Clariane SE (LTS:0OPS), the current Shares Outstanding (EOP) is 357 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clariane SE (LTS:0OPS) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.10 is trading 64.8% above its estimated GF Value™ of €2.49. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for LTS:0OPS:

  • Shares Outstanding (EOP): 357 Mil
  • GF Value™: €2.49 vs. price of €4.10 (64.8% above fair value)
  • GF Score™: 61/100 with 9 warning signs

No single metric tells the full story. See the LTS:0OPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score

Get the complete analysis for LTS:0OPS

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.10
Price
€2.49
GF Value